157 related articles for article (PubMed ID: 35253815)
1. Iron oxide nanoparticles as a drug carrier reduce host immunosuppression for enhanced chemotherapy.
Zhou B; Liu J; Wang L; Wang M; Zhao C; Lin H; Liang Y; Towner RA; Chen WR
Nanoscale; 2022 Mar; 14(12):4588-4594. PubMed ID: 35253815
[TBL] [Abstract][Full Text] [Related]
2. In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug methotrexate to MCF-7 breast cancer cells.
Murawala P; Tirmale A; Shiras A; Prasad BL
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():158-67. PubMed ID: 24268245
[TBL] [Abstract][Full Text] [Related]
3. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery.
Nosrati H; Abhari F; Charmi J; Davaran S; Danafar H
Bioorg Chem; 2019 Jul; 88():102959. PubMed ID: 31075743
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
6. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line.
Faghfoori MH; Nosrati H; Rezaeejam H; Charmi J; Kaboli S; Johari B; Danafar H
Int J Pharm; 2020 May; 582():119320. PubMed ID: 32278720
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
9. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery.
Li C; Xing L; Che S
Dalton Trans; 2012 Apr; 41(13):3714-9. PubMed ID: 22370556
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells.
Morovati A; Ahmadian S; Jafary H
Mol Biol Rep; 2019 Oct; 46(5):5033-5039. PubMed ID: 31278563
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insight into differential interactions of iron oxide nanoparticles with native, glycated albumin and their effect on erythrocytes parameters.
Nisar A; Ajabia DK; Agrawal SB; Varma S; Chaudhari BP; Tupe RS
Int J Biol Macromol; 2022 Jul; 212():232-247. PubMed ID: 35597380
[TBL] [Abstract][Full Text] [Related]
12. Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy.
Phuong PTT; Lee S; Lee C; Seo B; Park S; Oh KT; Lee ES; Choi HG; Shin BS; Youn YS
Colloids Surf B Biointerfaces; 2018 Nov; 171():123-133. PubMed ID: 30025374
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier.
Attari E; Nosrati H; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774
[TBL] [Abstract][Full Text] [Related]
14. BSA-based Cu
Liu Z; Chan L; Ye X; Bai Y; Chen T
Colloids Surf B Biointerfaces; 2018 Dec; 172():298-307. PubMed ID: 30173097
[TBL] [Abstract][Full Text] [Related]
15. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
16. IR780 loaded sulfobetaine methacrylate-functionalized albumin nanoparticles aimed for enhanced breast cancer phototherapy.
Alves CG; de Melo-Diogo D; Lima-Sousa R; Correia IJ
Int J Pharm; 2020 May; 582():119346. PubMed ID: 32315749
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
18. The Synergistic Effect of Hyperthermia and Chemotherapy in Magnetite Nanomedicine-Based Lung Cancer Treatment.
Yang SJ; Huang CH; Wang CH; Shieh MJ; Chen KC
Int J Nanomedicine; 2020; 15():10331-10347. PubMed ID: 33376324
[TBL] [Abstract][Full Text] [Related]
19. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
20.
Xu S; Wang J; Wei Y; Zhao H; Tao T; Wang H; Wang Z; Du J; Wang H; Qian J; Ma K; Wang J
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56701-56711. PubMed ID: 33296181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
